Donaldson Capital Management LLC Sells 219 Shares of McKesson Co. (NYSE:MCK)

Donaldson Capital Management LLC decreased its position in shares of McKesson Co. (NYSE:MCK) by 26.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 613 shares of the company’s stock after selling 219 shares during the period. Donaldson Capital Management LLC’s holdings in McKesson were worth $284,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in MCK. Covestor Ltd boosted its position in McKesson by 72.3% during the 1st quarter. Covestor Ltd now owns 81 shares of the company’s stock worth $25,000 after buying an additional 34 shares during the period. OFI Invest Asset Management bought a new position in shares of McKesson during the third quarter valued at about $26,000. Legacy Financial Group LLC bought a new stake in shares of McKesson in the 3rd quarter worth approximately $27,000. Live Oak Investment Partners purchased a new position in shares of McKesson in the fourth quarter worth about $30,000. Finally, BKM Wealth Management LLC bought a new position in shares of McKesson in the fourth quarter worth $31,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity

In related news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now owns 43,445 shares in the company, valued at approximately $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,511 shares in the company, valued at approximately $749,456. The disclosure for this sale can be found here. Insiders own 0.21% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Mizuho increased their target price on shares of McKesson from $450.00 to $505.00 and gave the stock a “neutral” rating in a report on Friday, February 9th. Barclays initiated coverage on shares of McKesson in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $537.00 target price for the company. Morgan Stanley upped their target price on McKesson from $522.00 to $548.00 and gave the stock an “overweight” rating in a research note on Monday. StockNews.com lowered shares of McKesson from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 4th. Finally, SVB Leerink assumed coverage on McKesson in a research note on Monday, February 26th. They set an “outperform” rating and a $600.00 target price for the company. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $533.50.

McKesson Trading Up 1.2 %

McKesson stock traded up $6.22 during trading on Tuesday, hitting $528.90. 65,150 shares of the company were exchanged, compared to its average volume of 688,034. The company has a market capitalization of $69.50 billion, a P/E ratio of 23.68, a PEG ratio of 1.42 and a beta of 0.45. The business’s 50 day moving average is $523.34 and its 200 day moving average is $484.53. McKesson Co. has a 52 week low of $352.34 and a 52 week high of $543.00.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, beating the consensus estimate of $7.05 by $0.69. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The company had revenue of $80.90 billion during the quarter, compared to analysts’ expectations of $77.93 billion. During the same quarter in the previous year, the company earned $6.90 earnings per share. McKesson’s revenue for the quarter was up 14.8% on a year-over-year basis. Equities analysts expect that McKesson Co. will post 27.59 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 1st were given a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Thursday, February 29th. McKesson’s payout ratio is 11.24%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.